{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:01:54Z","timestamp":1775545314500,"version":"3.50.1"},"reference-count":22,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMJ"],"DOI":"10.4274\/mmj.galenos.2025.95690","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T07:17:01Z","timestamp":1767165421000},"source":"Crossref","is-referenced-by-count":0,"title":["Machine Learning-Based Analysis of Serum Interleukin-39 and Interleukin-40 Levels for Differentiating Rheumatoid Arthritis and Systemic Lupus Erythematosus"],"prefix":"10.4274","author":[{"given":"Inas K.","family":"SHARQUIE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiq Isho","family":"GORIAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahraa Adnan","family":"AL-GHURAIBAWI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal Mahdi","family":"AL RUBAYE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"GS","year":"2017","unstructured":"1. Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immuni-ty. 2017;46:183-96.","journal-title":"Immuni-ty"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","unstructured":"2. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110-21.","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/ar395","article-title":"Autoanti-body systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value","volume":"4","author":"van Boekel","year":"2002","unstructured":"3. van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ. Autoanti-body systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res. 2002;4:87-93.","journal-title":"Arthritis Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-3083.2012.02728.x","article-title":"Antinuclear antibodies in rheumatic disease: a proposal for a func-tion-based classification","volume":"76","author":"Pisetsky","year":"2012","unstructured":"4. Pisetsky DS. Antinuclear antibodies in rheumatic disease: a proposal for a func-tion-based classification. Scand J Immunol. 2012;76:223-8.","journal-title":"Scand J Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/antib13010010","article-title":"Immunotherapy strategy for systemic autoimmune diseases: betting on CAR-T cells and antibodies","volume":"13","author":"Chasov","year":"2024","unstructured":"5. Chasov V, Zmievskaya E, Ganeeva I, et al. Immunotherapy strategy for systemic autoimmune diseases: betting on CAR-T cells and antibodies. Antibodies (Ba-sel). 2024;13:10.","journal-title":"Antibodies (Ba-sel)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1371620","DOI":"10.3389\/fimmu.2024.1371620","article-title":"Mathematical modeling in autoimmune dis-eases: from theory to clinical application","volume":"15","author":"Ugolkov","year":"2024","unstructured":"6. Ugolkov Y, Nikitich A, Leon C, et al. Mathematical modeling in autoimmune dis-eases: from theory to clinical application. Front Immunol. 2024;15:1371620.","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/eji.201546095","article-title":"A novel IL-23p19\/Ebi3 (IL-39) cytokine mediates in-flammation in lupus-like mice","volume":"46","author":"Wang","year":"2016","unstructured":"7. Wang X, Wei Y, Xiao H, et al. A novel IL-23p19\/Ebi3 (IL-39) cytokine mediates in-flammation in lupus-like mice. Eur J Immunol. 2016;46:1343-50.","journal-title":"Eur J Immunol"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Dabbagh-Gorjani F. A comprehensive review on the role of interleukin-40 as a bi-omarker for diagnosing inflammatory diseases. Autoimmune Dis. 2024;2024:3968767.","DOI":"10.1155\/2024\/3968767"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ejr.2022.07.007","article-title":"Diagnostic potential of interleukin-40 (IL-40) in rheumatoid arthritis patients","volume":"44","author":"Ghuraibawi Z","year":"2022","unstructured":"9. Ag Al Ghuraibawi Z, Sharquie IK, Gorial FI. Diagnostic potential of interleukin-40 (IL-40) in rheumatoid arthritis patients. The Egyptian Rheumatologist. 2022;44:377-80.","journal-title":"The Egyptian Rheumatologist"},{"key":"ref9","unstructured":"10. Al Rubaye AM, Sharquie IK, Gorial FI. Serum interleukin 40: an innovative diagnos-tic biomarker for patients with systemic lupus erythematosus. Med J Malaysia. 2023;78:609-15."},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Al-Qudimat AR, Fares ZE, Elaarag M, Osman M, Al-Zoubi RM, Aboumarzouk OM. Advancing medical research through artificial intelligence: progressive and trans-formative strategies: a literature review. Health Sci Rep. 2025;8:e70200.","DOI":"10.1002\/hsr2.70200"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1477130","DOI":"10.3389\/fimmu.2024.1477130","article-title":"Artificial intelligence for predicting treatment responses in autoimmune rheumatic diseases: advancements, chal-lenges, and future perspectives","volume":"15","author":"Yang","year":"2024","unstructured":"12. Yang Y, Liu Y, Chen Y, Luo D, Xu K, Zhang L. Artificial intelligence for predicting treatment responses in autoimmune rheumatic diseases: advancements, chal-lenges, and future perspectives. Front Immunol. 2024;15:1477130.","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification cri-teria: an American College of Rheumatology\/European League Against Rheuma-tism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","unstructured":"13. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification cri-teria: an American College of Rheumatology\/European League Against Rheuma-tism collaborative initiative. Arthritis Rheum. 2010;62:2569-81.","journal-title":"Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheu-matism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","unstructured":"14. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheu-matism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71:1400-12.","journal-title":"Arthritis Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Al Ghuraibawi ZAG, Sharquie IK, Gorial FI. A novel link of serum IL-39 levels in pa-tients with rheumatoid arthritis. Iraqi Journal of Science. 2023:1651-6.","DOI":"10.24996\/ijs.2023.64.4.8"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.24996\/ijs.2024.65.10.17","article-title":"Novel insights into the role of serum inter-leukin-39 in patients with systemic lupus erythematosus","volume":"65","author":"Al Rubaye","year":"2024","unstructured":"16. Al Rubaye AM, Sharquie IK, Gorial FI. Novel insights into the role of serum inter-leukin-39 in patients with systemic lupus erythematosus. Iraqi Journal of Sci-ence. 2024;65:5518-31.","journal-title":"Iraqi Journal of Sci-ence"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1515469","DOI":"10.3389\/fimmu.2024.1515469","article-title":"Immune complexes-mediated activation of neutrophils in systemic lupus erythematosus is dependent on RNA recognition by toll-like receptor 8","volume":"15","author":"Wang","year":"2024","unstructured":"17. Wang T, Kuley R, Hermanson P, et al. Immune complexes-mediated activation of neutrophils in systemic lupus erythematosus is dependent on RNA recognition by toll-like receptor 8. Front Immunol. 2024;15:1515469.","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40164-022-00286-x","article-title":"IL-39 promotes chronic graft-versus-host disease by in-creasing T and B Cell pathogenicity","volume":"11","author":"Lv","year":"2022","unstructured":"18. Lv K, Hu B, Xu M, et al. IL-39 promotes chronic graft-versus-host disease by in-creasing T and B Cell pathogenicity. Exp Hematol Oncol. 2022;11:34.","journal-title":"Exp Hematol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"745523","DOI":"10.3389\/fimmu.2021.745523","article-title":"IL-40: a new B cell-associated cytokine up-regulated in rheumatoid arthritis decreases following the rituximab therapy and correlates with disease activity, autoantibodies, and NETosis","volume":"12","author":"Navr\u00e1tilov\u00e1","year":"2021","unstructured":"19. Navr\u00e1tilov\u00e1 A, Andr\u00e9s Cerezo L, Hulejov\u00e1 H, et al. IL-40: a new B cell-associated cytokine up-regulated in rheumatoid arthritis decreases following the rituximab therapy and correlates with disease activity, autoantibodies, and NETosis. Front Immunol. 2021;12:745523.","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","unstructured":"20. Breiman L. Random forests. Machine Learning. 2001;45:5-32.","journal-title":"Machine Learning"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","article-title":"Deep learning","volume":"521","author":"LeCun","year":"2015","unstructured":"21. LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436-44.","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1409555","DOI":"10.3389\/fimmu.2024.1409555","article-title":"Advancing precision rheumatology: applications of machine learning for rheumatoid arthritis management","volume":"15","author":"Shi","year":"2024","unstructured":"22. Shi Y, Zhou M, Chang C, et al. Advancing precision rheumatology: applications of machine learning for rheumatoid arthritis management. Front Immunol. 2024;15:1409555.","journal-title":"Front Immunol"}],"container-title":["Medeniyet Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:04:29Z","timestamp":1775541869000},"score":1,"resource":{"primary":{"URL":"https:\/\/medeniyetmedicaljournal.org\/articles\/doi\/MMJ.galenos.2025.95690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":22,"URL":"https:\/\/doi.org\/10.4274\/mmj.galenos.2025.95690","relation":{},"ISSN":["2149-2042"],"issn-type":[{"value":"2149-2042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}